Haleon (NYSE:HLN) Sees Large Volume Increase

Haleon plc (NYSE:HLN) saw unusually-strong trading volume on Friday . Approximately 9,139,235 shares traded hands during trading, an increase of 121% from the previous session’s volume of 4,141,510 shares.The stock last traded at $8.26 and had previously closed at $8.25.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on HLN shares. Investec upgraded shares of Haleon from a “sell” rating to a “hold” rating in a research report on Tuesday, August 8th. Stifel Nicolaus started coverage on shares of Haleon in a research report on Wednesday, May 24th. They issued a “hold” rating for the company. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $364.00.

Haleon Stock Up 0.2 %

The company has a debt-to-equity ratio of 0.53, a current ratio of 0.84 and a quick ratio of 0.54. The firm’s 50 day simple moving average is $8.37 and its two-hundred day simple moving average is $8.37.

Haleon (NYSE:HLN) last posted its quarterly earnings results on Wednesday, August 2nd. The company reported $0.08 earnings per share for the quarter. The business had revenue of $3.44 billion during the quarter. On average, equities analysts anticipate that Haleon plc will post 0.45 EPS for the current fiscal year.

Haleon Cuts Dividend

The firm also recently declared a — dividend, which will be paid on Thursday, October 5th. Shareholders of record on Friday, August 25th will be paid a $0.046 dividend. This represents a yield of 1.3%. The ex-dividend date of this dividend is Thursday, August 24th.

Institutional Trading of Haleon

Several hedge funds have recently added to or reduced their stakes in the business. Ironwood Wealth Management LLC. bought a new position in shares of Haleon during the third quarter valued at about $70,000. Tower Research Capital LLC TRC bought a new position in shares of Haleon during the third quarter valued at about $115,000. Credit Suisse AG bought a new position in shares of Haleon during the third quarter valued at about $76,000. Guggenheim Capital LLC bought a new position in shares of Haleon during the third quarter valued at about $119,000. Finally, BlackRock Inc. bought a new position in shares of Haleon during the third quarter valued at about $10,366,000. 6.67% of the stock is owned by institutional investors.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.